FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:275-285 July 21, 2005 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Supplementary Material Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Hormones and growth factors act on stromal and epithelial cells to regulate the development, maturation, and differentiation of mammary-gland cells.^1,2 Broadly summarized, estrogen mediates the development and elongation of ductal tissue, progesterone facilitates ductal branching and lobulo–alveolar development, and prolactin regulates the production of milk protein. At puberty, estradiol and progesterone levels increase to initiate breast development. A complex tree-like structure results, comprising 5 to 10 primary milk ducts that originate at the nipple, 20 to 40 segmental ducts, and 10 to 100 subsegmental ducts that end in glandular units called terminal-duct lobular units.³ In the adult breast, cyclic changes . . . [Full Text of this Article]

Changes in the Normal Breast

Classification of Benign Breast Lesions

Causal Factors in Benign Breast Disorders

Progression to Malignant Disease

Clinical Features of Benign Breast Disease

Breast Pain

Nonbreast Pain

Nipple Discharge

Focal and Diffuse Breast Lumps

Abnormalities Associated with an Increased Risk of Breast Cancer

Practical Management

Treatment

Cyclic Breast Pain

Noncyclic Pain

Focal Lesions

Nipple Discharge

Prevention of Breast Cancer

Source Information

From the Department of Medicine, University of Virginia Health Sciences Center, Charlottesville (R.J.S.); and the Department of Surgery, University of Wales College of Medicine, Cardiff, Wales, United Kingdom (R.M.).

Address reprint requests to Dr. Santen at the University of Virginia, P.O. Box 801416, Charlottesville, VA 22908, or at rjs5y@virginia.edu.

This article has been cited by other articles:

• Yu, K.-D., Di, G.-H., Yuan, W.-T., Fan, L., Wu, J., Hu, Z., Shen, Z.-Z., Zheng, Y., Huang, W., Shao, Z.-M. (2009). Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet 18: 2502-2517 [Abstract] [Full Text]  
• Yu, K.-D., Di, G.-H., Fan, L., Wu, J., Hu, Z., Shen, Z.-Z., Huang, W., Shao, Z.-M. (2009). A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. FASEB J. 23: 2274-2287 [Abstract] [Full Text]  
• Pankratz, V. S., Hartmann, L. C., Degnim, A. C., Vierkant, R. A., Ghosh, K., Vachon, C. M., Frost, M. H., Maloney, S. D., Reynolds, C., Boughey, J. C. (2008). Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia. JCO 26: 5374-5379 [Abstract] [Full Text]  
• Nofech-Mozes, S., Holloway, C., Hanna, W. (2008). The Role of Cytokeratin 5/6 as an Adjunct Diagnostic Tool in Breast Core Needle Biopsies. INT J SURG PATHOL 16: 399-406 [Abstract]  
• Schwab, S. A., Uder, M., Schulz-Wendtland, R., Bautz, W. A., Janka, R., Wenkel, E. (2008). Direct MR Galactography: Feasibility Study. Radiology 249: 54-61 [Abstract] [Full Text]  
• Bogorad, R. L., Courtillot, C., Mestayer, C., Bernichtein, S., Harutyunyan, L., Jomain, J.-B., Bachelot, A., Kuttenn, F., Kelly, P. A., Goffin, V., Touraine, P., the Benign Breast Diseases Study Group, (2008). Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc. Natl. Acad. Sci. USA 105: 14533-14538 [Abstract] [Full Text]  
• Rohan, T. E., Negassa, A., Chlebowski, R. T., Lasser, N. L., McTiernan, A., Schenken, R. S., Ginsberg, M., Wassertheil-Smoller, S., Page, D. L. (2008). Estrogen plus Progestin and Risk of Benign Proliferative Breast Disease. Cancer Epidemiol. Biomarkers Prev. 17: 2337-2343 [Abstract] [Full Text]  
• Rohan, T. E., Negassa, A., Caan, B., Chlebowski, R. T., Curb, J. D., Ginsberg, M., Lane, D. S., Neuhouser, M. L., Shikany, J. M., Wassertheil-Smoller, S., Page, D. L. (2008). Low-Fat Dietary Pattern and Risk of Benign Proliferative Breast Disease: A Randomized, Controlled Dietary Modification Trial. Cancer Prevention Research 1: 275-284 [Abstract] [Full Text]  
• Rohan, T. E., Negassa, A., Chlebowski, R. T., Habel, L., McTiernan, A., Ginsberg, M., Wassertheil-Smoller, S., Page, D. L. (2008). Conjugated Equine Estrogen and Risk of Benign Proliferative Breast Disease: A Randomized Controlled Trial. JNCI J Natl Cancer Inst 100: 563-571 [Abstract] [Full Text]  
• Sklair-Levy, M., Sella, T., Alweiss, T., Craciun, I., Libson, E., Mally, B. (2008). Incidence and Management of Complex Fibroadenomas. Am. J. Roentgenol. 190: 214-218 [Abstract] [Full Text]  
• Chlebowski, R. T., Anderson, G. L., Lane, D. S., Aragaki, A. K., Rohan, T., Yasmeen, S., Sarto, G., Rosenberg, C. A., Hubbell, F. A., For the Women's Health Initiative Investigators, (2007). Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status. JNCI J Natl Cancer Inst 99: 1695-1705 [Abstract] [Full Text]  
• Mannello, F., Tonti, G. A.M. (2006). Benign Breast Diseases: Classification, Diagnosis, and Management. The Oncologist 11: 1132-1134 [Full Text]  
• Manhes, C., Kayser, C., Bertheau, P., Kelder, B., Kopchick, J. J, Kelly, P. A, Touraine, P., Goffin, V. (2006). Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.. J Endocrinol 190: 271-285 [Abstract] [Full Text]  
• Guray, M., Sahin, A. A. (2006). Benign breast diseases: classification, diagnosis, and management.. The Oncologist 11: 435-449 [Abstract] [Full Text]